Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06121401 |
| Title | First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients (IOLANTHE) |
| Acronym | IOLANTHE |
| Recruitment | Recruiting |
| Gender | female |
| Phase | FDA approved |
| Variant Requirements | No |
| Sponsors | Mario Negri Institute for Pharmacological Research |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ITA |